Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation

References

• Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013;112:1142-7
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64
   PubMed Web of Science ®Google Scholar
• Kim MH, Johnston SS, Chu B-C, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011;4:313-20
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Essebag V. Economic burden of atrial fibrillation: implications for intervention. Am J Pharm Benefits 2012;4:58-65
   Google Scholar
• Goldberg A, Menen M, Mickelsen S, et al. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J Interv Card Electrophysiol Int J Arrhythm Pacing 2003;8:59-64
   PubMed Web of Science ®Google Scholar
• Ladapo JA, David G, Gunnarsson CL, et al. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol 2012;23:1-8
   Google Scholar
• Bunch TJ, May HT, Bair TL, et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm Off J Heart Rhythm Soc 2013;10:1272-7
   PubMed Web of Science ®Google Scholar
• Chao T-F, Tsao H-M, Lin Y-J, et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol 2012;5:514-20
   PubMed Web of Science ®Google Scholar
• Sorgente A, Tung P, Wylie J, et al. Six year follow-up after catheter ablation of atrial fibrillation: a palliation more than a true cure. Am J Cardiol 2012;109:1179-86
   Google Scholar
• Tilz RR, Rillig A, Thum A-M, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 2012;60:1921-9
   PubMed Web of Science ®Google Scholar
• Chilukuri K, Scherr D, Dalal D, et al. Conventional pulmonary vein isolation compared with the ‘box isolation’ method: a randomized clinical trial. J Interv Card Electrophysiol Int J Arrhythm Pacing 2011;32:137-46
   Google Scholar
• Chan PS, Vijan S, Morady F, et al. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol 2006;47:2513-20
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Zimetbaum P, Josephson ME, et al. Cost-effectiveness of radiofrequency catheter ablation compared with anti-arrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2009;2:362-9
   PubMed Web of Science ®Google Scholar
• McKenna C, Palmer S, Rodgers M, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart Br Card Soc 2009;95:542-9
   Google Scholar
• Civello KC, Smith CA, Boedefeld W. Combined endocardial and epicardial ablation for symptomatic atrial fibrillation: single center experience in 100+ consecutive patients. J Innov Card Rhythm Manag 2013;4:1367-73
   Google Scholar
• Geršak B, Zembala MO, Müller D, et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients. J Thorac Cardiovasc Surg 2013;147:1411-6
   Google Scholar
• Robinson, MC. Maximizing ablation, limiting invasiveness, and being realistic about atrial fibrillation: the convergent hybrid ablation procedure for advanced AF. EP Lab Dig 2013;13:34-6
   Google Scholar
• Thosani AJ, Gerczuk P, Liu E, et al. Closed chest convergent epicardial–endocardial ablation of non-paroxysmal atrial fibrillation – a case series and literature review. Arrhythmia Electrophysiol Rev 2013;2:65-8
   Google Scholar
• Toplisek J, Pernat A, Gersak B, et al. Effect of convergent procedure on left atrial size & ventricular function in patients with persistent atrial fibrillation. J Am Coll Cardiol 2012;59(13 Suppl 1):E594
   Google Scholar
• Golden K, Olson J, Walts P, et al. Clinical outcomes of a new epicardial/endocardial ablation procedure (convergent) for the treatment of atrial fibrillation. Presentation PO04-67 Heart Rhythm Society Boston. Heart Rhythm 2012;9(5 Suppl):S292-S328
   Google Scholar
• Gersak B, Pernat A, Robic B, et al. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2012;23:1059-66
   PubMed Web of Science ®Google Scholar
• Gilligan DM, Joyner CA, Bundy GM. Multidisciplinary collaboration for the treatment of atrial fibrillation: convergent procedure outcomes from a single center. J Innov Card Rhythm Manag 2013;4:1396-403
   Google Scholar
• Zembala M, Filipiak K, Kowalski O, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol 2012;70:819-28
   Google Scholar
• Dixit S, Marchlinski FE, Lin D, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol 2012;5:287-94
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Taniguchi H, Komatsu Y, et al. Sequential biatrial linear defragmentation approach for persistent atrial fibrillation. Heart Rhythm Off J Heart Rhythm Soc 2013;10:338-46
   Google Scholar
• Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008;51:843-9
   PubMed Web of Science ®Google Scholar
• Piccini JP, Sinner MF, Greiner MA, et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 2012;126:2200-7
   PubMed Web of Science ®Google Scholar
• Shah RU, Freeman JV, Shilane D, et al. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012;59:143-9
   PubMed Web of Science ®Google Scholar
• Gage BFWA. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 2001;285:2864-70
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke J Cereb Circ 1991;22:983-8
   Google Scholar
• Mercaldi CJ, Ciarametaro M, Hahn B, et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation. Stroke J Cereb Circ 2011;42:112-18
   Google Scholar
• Meiltz A, Zimmermann M, Urban P, et al, Association of Cardiologists of the Canton of Geneva. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 2008;10:674-80
   Google Scholar
• Nieuwlaat R, Prins MH, Le Heuzey J-Y, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008;29:1181-9
   PubMed Web of Science ®Google Scholar
• Lee WC, Lamas GA, Balu S, et al. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ 2008;11:281-98
   PubMedGoogle Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-84
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5
   PubMed Web of Science ®Google Scholar
• Le Heuzey J-Y, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004;147:121-6
   PubMed Web of Science ®Google Scholar
• Older Americans & Cardiovascular Diseases. American Heart Association, American Stroke Association, 2013. Available at: http://www.heart.org/idc/groups/heart-public/@wcm/@sop/@smd/documents/downloadable/ucm_319574.pdf [Last accessed 21 July 2013]
   Google Scholar
• Amin AN, Jhaveri M, Lin J. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors. Adv Ther 2011;28:907-26
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Essebag V, Zimetbaum P, et al. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol 2007;18:628-33
   PubMed Web of Science ®Google Scholar
• Amin AN, Jhaveri M, Lin J. Hospital readmissions in US atrial fibrillation patients: occurrence and costs. Am J Ther 2013;20:143-50
   PubMed Web of Science ®Google Scholar
• Casciano JP, Dotiwala ZJ, Martin BC, et al. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm 2013;19:302-16
   PubMed Web of Science ®Google Scholar
• Poulin F, Khairy P, Roy D, et al. Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs rate-control strategies. Can J Cardiol 2013;29:1256-62
   Google Scholar
• Torp-Pedersen C, Crijns HJGM, Gaudin C, et al. Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. Europace 2011;13:1118-26
   PubMed Web of Science ®Google Scholar
• Mercaldi CJ, Siu K, Sander SD, et al. Long-term costs of ischemic stroke and major bleeding events among Medicare patients with nonvalvular atrial fibrillation. Cardiol Res Pract 2012;2012:645469
   PubMedGoogle Scholar
• Chen LM, Jha AK, Guterman S, et al. Hospital cost of care, quality of care, and readmission rates: penny wise and pound foolish? Arch Intern Med 2010;170:340-6
   PubMedGoogle Scholar
• Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes 2011;4:68-75
   PubMed Web of Science ®Google Scholar
• Coyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health J Int Soc Pharmacoeconomics Outcomes Res 2006;9:348-56
   PubMed Web of Science ®Google Scholar
• Gula LJ, Massel D, Redfearn DP, et al. Impact of routine transoesophageal echocardiography on safety, outcomes, and cost of pulmonary vein ablation: inferences drawn from a decision analysis model. Europace 2010;12:1550-7
   Google Scholar
• Ollendorf DA, Silverstein MD, Bobo T, Pearson SD. Rhythm Control and Stroke Prevention Strategies for Patients with Atrial Fibrillation. 2010. Available at: http://www.icer-review.org/index.php/Reports/rhythm-control-and-sroke-prevention-strategies-for-patients-with-atrial-fibrillation-final-appraisal.html [Last accessed 12 June 2013]
   Google Scholar
• Gaztañaga L, Frankel DS, Kohari M, et al. Time to recurrence of atrial fibrillation influences outcome following catheter ablation. Heart Rhythm Off J Heart Rhythm Soc 2013;10:2-9
   PubMed Web of Science ®Google Scholar
• Sotomi Y, Inoue K, Ito N, et al. Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace 2013;15:1581-6
   Google Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57
   Google Scholar
• Kannel W, Benjamin E. Final draft status of the epidemiology of atrial fibrillation. Med Clin North Am 2008;92:17-40, ix
   PubMed Web of Science ®Google Scholar
• Camm AJ, Breithardt G, Crijns H, et al. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 2011;58:493-501
   PubMedGoogle Scholar
• Steinberg BA, Holmes DN, Ezekowitz MD, et al. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 2013;165:622-9
   Google Scholar
• Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin 2005;21:1693-9
   PubMed Web of Science ®Google Scholar
• Piccini JP, Lopes RD, Kong MH, et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2:626-33
   PubMed Web of Science ®Google Scholar
• Kleinman NL, Rohrbacker NJ, White SA, et al. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system. J Occup Environ Med Am Coll Occup Environ Med 2011;53:405-14
   Google Scholar